SEC Form 6-K filed by Kazia Therapeutics Limited

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form or Form

Form Form

Indicate by check mark if the registrant is submitting the Form in paper as permitted by Regulation Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form in paper as permitted by Regulation Rule 101(b)(7): ☐

 

 

On June 9, 2025, Kazia Therapeutics Limited (the “Company”) reported its unaudited half-year results for the six months ended December 31, 2024, a copy of which is attached to this Form as Exhibit 99.1.

The Company hereby incorporates by reference the information contained herein into the Company’s registration statements on Form (File and